Influenza vaccine, split inactivated
Phase 1Completed 0 watching 0 views this week💤 Quiet
25
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Influenza, Human
Conditions
Influenza, Human
Trial Timeline
Nov 1, 2015 → Mar 1, 2016
NCT ID
NCT02585700About Influenza vaccine, split inactivated
Influenza vaccine, split inactivated is a phase 1 stage product being developed by Comac Medical for Influenza, Human. The current trial status is completed. This product is registered under clinical trial identifier NCT02585700. Target conditions include Influenza, Human.
Hype Score Breakdown
Clinical
10
Activity
5
Company
2
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02585700 | Phase 1 | Completed |
Competing Products
20 competing products in Influenza, Human